TAM
LJPC

Tocqueville Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Tocqueville Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,650
Closed -$252K – 873
2018
Q2 		$252K Buy
8,650
+800
+10% +$24.7K ﹤0.01% 732
2018
Q1 		$234K Buy
+7,850
New +$253K ﹤0.01% 751
2017
Q3 		– Sell
-70,150
Closed -$2.09M – 864
2017
Q2 		$2.09M Buy
70,150
+100
+0.1% +$2.87K 0.03% 421
2017
Q1 		$2.09M Buy
70,050
+20,050
+40% +$512K 0.03% 417
2016
Q4 		$877K Buy
50,000
+12,100
+32% +$232K 0.01% 506
2016
Q3 		$902K Buy
37,900
+1,500
+4% +$28.3K 0.01% 521
2016
Q2 		$582K Hold
36,400
– – 0.01% 607
2016
Q1 		$761K Buy
36,400
+6,000
+20% +$107K 0.01% 548
2015
Q4 		$821K Buy
30,400
+22,900
+305% +$624K 0.01% 576
2015
Q3 		$208K Buy
+7,500
New +$236K ﹤0.01% 888
2014
Q3 		– Sell
-28,225
Closed -$259K – 1616
2014
Q2 		$259K Buy
28,225
+1,500
+6% +$13.7K ﹤0.01% 910
2014
Q1 		$289K Buy
+26,725
New +$262K ﹤0.01% 711

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Tocqueville Asset Management's LJPC Position: Q3 2018 in Review

Tocqueville Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2018, closing a stake of 8,650 shares — an estimated $252K sold.

Tocqueville Asset Management first reported a position in LJPC in Q1 2014 and held it in 12 quarters. The position peaked at $2.09M in Q1 2017. 78 funds tracked by Wall St. Rank hold LJPC as of Q3 2018.

  • Tocqueville Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2018 after selling out during the quarter.
  • Tocqueville Asset Management sold 8,650 La Jolla Pharmaceutical Company shares in Q3 2018, an estimated $252K.
  • Tocqueville Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 12 quarters.
  • Tocqueville Asset Management's La Jolla Pharmaceutical Company position peaked at $2.09M in Q1 2017.
  • 78 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2018.

Based on Tocqueville Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.